CLN5 Antikörper (C-Term)
Kurzübersicht für CLN5 Antikörper (C-Term) (ABIN5517800)
Target
Alle CLN5 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Sequenz
- DNETGIYYET WNVKASPEKG AETWFDSYDC SKFVLRTFNK LAEFGAEFKN
-
Homologie
- Cow: 77%, Dog: 79%, Guinea Pig: 79%, Horse: 86%, Human: 100%, Pig: 86%, Rabbit: 86%, Rat: 79%
-
Aufreinigung
- Affinity purified
-
Immunogen
- The immunogen is a synthetic peptide directed towards the C terminal region of human CLN5
-
-
-
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
-
-
- CLN5 (Ceroid-Lipofuscinosis, Neuronal 5 (CLN5))
-
Andere Bezeichnung
- CLN5
-
Hintergrund
-
This gene is one of eight which have been associated with neuronal ceroid lipofuscinoses (NCL). Also referred to as Batten disease, NCL comprises a class of autosomal recessive, neurodegenerative disorders affecting children. The genes responsible likely encode proteins involved in the degradation of post-translationally modified proteins in lysosomes. The primary defect in NCL disorders is thought to be associated with lysosomal storage function.
Alias Symbols: NCL
Protein Interaction Partner: ARHGAP36, FBXO27, SPNS1, SFXN3, SLC25A22, SEC61A1, FBXO6, PHGDH, GANAB, OS9, CDIPT, SLC25A13, CDS2, SLC25A11, XPO1, SLC25A1, SEL1L, RPN1, RCN2, HMGCS1, DBH, CLN5, CLGN, CANX, CALU, CALR, ATP2A2, ATP1A3, ARF4, SLC25A6, SLC25A5, SLC25A4, Dlg4, UBC, KRT8,
Protein Size: 358 -
Gen-ID
- 1203
-
NCBI Accession
- NM_006493, NP_006484
-
UniProt
- O75503
Target
-